CRL Charles River Laboratories Inte | US1598641074
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | 10.913.844.224 | 8.308.807.500 | 9.817.806.949,72 | 7.700.179.230,42 |
| Enterprise Value | 13.834.265.600 | 11.173.223.500 | 12.174.444.949,72 | 10.121.720.230,42 |
| Trailing P/E | - | - | - | 58,24 |
| Forward P/E | 18,38 | - | - | - |
| Price to Sales | 2,71 | 2,06 | 2,45 | 2,55 |
| Price to Book | 3,71 | 2,83 | 3,1 | 2,26 |
| EV/Revenue | 3,44 | 2,77 | 3,03 | 3,35 |
| EV/EBITDA | 15,55 | 38,45 | 29,63 | 16,79 |